PDCD1 and cancer: In particular, the cancer cells bind and activate the co-inhibitory molecules on the T lymphocyte surface, e.g., T lymphocyte-associated antigen 4 (CTLA4), programmed cell death protein 1 (PD1), lymphocyte activation gene 3 (LAG3) and T cell immunoglobulin mucin 3 (TIM3).